Effectiveness of Cross K-wire Vs Lateral Entry K-wire Fixation in Maintaining Reduction of Gartland Type 3 Supracondylar Fractures of Children

November 24, 2025 updated by: Laiba Qamar

Effectiveness of Cross K-wire Vs Lateral Entry K-wire Fixation in Maintaining Reduction of Gartland Type # Supracondylar Fractures of Children : A Comparative Study

This study compares the efficacy of K wire when inserted in Cross V/s Lateral Direction in Supracondylar fractures of Gartland Type 3 in children. A comparative study.

Study Overview

Detailed Description

This is a randomized control trial being done to compare the efficacy of Cross V/S Laterally Placed K wire In Supracondylar fractures to calculate and copmpare the Post K wire iinsertion range of motion . It is also intended to calculate the frequency of loss of reduction after lateral K wire in terms of Skaggs Criteria . This study intends to find the better method of K wire fixatio to avoid the post fixation loss of reduction.

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Punjab Province
      • Bahawalpur, Punjab Province, Pakistan, 16300
        • Recruiting
        • Bahawal Victoria Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

All male and female patients of age 02-13 years with Gartland type 3 Supracondylar Fracture of Humerus less than 7 days old

Exclusion Criteria:

patients with open fractures patients with neurovascular injuries patients with medial column communition Fractures more than 7 Days old Ipsilateral fractures of radius/ulna or shaft of humerus pathological fractures which are associated with bone density changes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group A
The participants enrolled in this arm will be treated with cross K wire fixation
In this intervention the K wire will be fixed in a Manner of Cross at the site of frature.
Experimental: Group B
The participants enrolled in this arm will be treated with lateral fixation of K wire after supracondylar fracture.
In this arm of intervention the K wire will be fixed laterally at the site of fracture.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
frequency of post K wire fixation loss of reduction
Time Frame: 2 months
It is comonly noted that after lateral K wire fixation there is more frequent loss of reduction as compared to cross fixation method. The frequency of loss of reduction will be noted after the intervention.
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2024

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

November 24, 2025

First Submitted That Met QC Criteria

November 24, 2025

First Posted (Actual)

December 5, 2025

Study Record Updates

Last Update Posted (Actual)

December 5, 2025

Last Update Submitted That Met QC Criteria

November 24, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • #CVSLKWIRE3#

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gartland Type 3 Supracondylar Fracture

Clinical Trials on Cross K Wire Fixation

Subscribe